MAI Wealth Advisors »

Cartesian Therapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $148 24 6.17

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Amazon Call Call Option (Principal) (AMZN)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Call Call Option (Principal) (GOOGL)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr S&p 500 Val Etf (IVE)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for MAI Wealth Advisors

Top funds holding Cartesian Therapeutics

Squarepoint Ops
FMR
BlackRock
Vanguard Group
Vanguard Capital Management
683 Capital Management
Millennium Management
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
Privium Fund Management B.V.
Marshall Wace
Two Sigma Investments
UBS Group
Citadel Advisors

View all funds holding Cartesian Therapeutics